These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 32759200)

  • 1. Patient-acceptable symptom states in myasthenia gravis.
    Mendoza M; Tran C; Bril V; Katzberg HD; Barnett C
    Neurology; 2020 Sep; 95(12):e1617-e1628. PubMed ID: 32759200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of the Italian version of the Myasthenia Gravis Impairment Index (MGII).
    Pasqualin F; Barnett C; Guidoni SV; Albertini E; Ermani M; Bonifati DM
    Neurol Sci; 2022 Mar; 43(3):2059-2064. PubMed ID: 34505205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myasthenia Gravis Impairment Index: Sensitivity for Change in Generalized Muscle Weakness.
    de Meel RHP; Barnett C; Bril V; Tannemaat MR; Verschuuren JJGM
    J Neuromuscul Dis; 2020; 7(3):297-300. PubMed ID: 32250313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the single simple question and the patient acceptable symptom state in myasthenia gravis.
    Menon D; Barnett C; Bril V
    Eur J Neurol; 2020 Nov; 27(11):2286-2291. PubMed ID: 32537828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The utility of a single simple question in the evaluation of patients with myasthenia gravis.
    Abraham A; Breiner A; Barnett C; Katzberg HD; Bril V
    Muscle Nerve; 2018 Feb; 57(2):240-244. PubMed ID: 28590545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Telephone consultation for myasthenia gravis care during the COVID-19 pandemic: Assessment of a novel virtual myasthenia gravis index.
    Menon D; Alnajjar S; Barnett C; Vijayan J; Katzberg H; Fathi D; Alcantara M; Bril V
    Muscle Nerve; 2021 Jun; 63(6):831-836. PubMed ID: 33792967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myasthenia Gravis Impairment Index: Responsiveness, meaningful change, and relative efficiency.
    Barnett C; Bril V; Kapral M; Kulkarni AV; Davis AM
    Neurology; 2017 Dec; 89(23):2357-2364. PubMed ID: 29101274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and validation of the Myasthenia Gravis Impairment Index.
    Barnett C; Bril V; Kapral M; Kulkarni A; Davis AM
    Neurology; 2016 Aug; 87(9):879-86. PubMed ID: 27402891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time to achieve a patient acceptable symptom state in myasthenia gravis.
    Martinez-Harms R; Barnett C; Bril V
    Front Neurol; 2023; 14():1187189. PubMed ID: 37396757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 'Minimal symptom expression' in patients with acetylcholine receptor antibody-positive refractory generalized myasthenia gravis treated with eculizumab.
    Vissing J; Jacob S; Fujita KP; O'Brien F; Howard JF;
    J Neurol; 2020 Jul; 267(7):1991-2001. PubMed ID: 32189108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The MG Composite: A valid and reliable outcome measure for myasthenia gravis.
    Burns TM; Conaway M; Sanders DB;
    Neurology; 2010 May; 74(18):1434-40. PubMed ID: 20439845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Developing outcome measures of disease activity in pediatric myasthenia.
    Prior DE; Cooper BA; Zhang B; Ghosh PS
    Muscle Nerve; 2021 May; 63(5):751-757. PubMed ID: 33604899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychometric Properties of the Quantitative Myasthenia Gravis Score and the Myasthenia Gravis Composite Scale.
    Barnett C; Merkies IS; Katzberg H; Bril V
    J Neuromuscul Dis; 2015 Sep; 2(3):301-311. PubMed ID: 27858737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Female sex and overweight are associated with a lower quality of life in patients with myasthenia gravis: a single center cohort study.
    Wilcke H; Glaubitz S; Kück F; Anten C; Liebetanz D; Schmidt J; Zschüntzsch J
    BMC Neurol; 2023 Oct; 23(1):366. PubMed ID: 37817097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reliability and Validity of Turkish Myasthenia Gravis-Activities of Daily Living Scale.
    Karanfil E; Salcı Y; Fil-Balkan A; Bekircan-Kurt CE; Erdem Özdamar S; Armutlu K
    OTJR (Thorofare N J); 2021 Apr; 41(2):101-107. PubMed ID: 33016212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minimal Manifestation Status Indicates a Stable State in Myasthenia Gravis: A Quantitative Study.
    Jiang P; Li J; Li HY; Zhang B; Yue YX; Wang SY; Zi XC; Liu SS; Li YF; Jiao LD; Li HF
    Front Neurol; 2022; 13():880045. PubMed ID: 35677340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gender differences in clinical outcomes in myasthenia gravis: A prospective cohort study.
    Thomsen JLS; Vinge L; Harbo T; Andersen H
    Muscle Nerve; 2021 Nov; 64(5):538-544. PubMed ID: 34036597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hope, Coping, and Quality of Life in Adults with Myasthenia Gravis.
    Koopman WJ; LeBlanc N; Fowler S; Nicolle MW; Hulley D
    Can J Neurosci Nurs; 2016; 38(1):56-64. PubMed ID: 27468602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative Myasthenia Gravis Score: a Brazilian multicenter study for translation, cultural adaptation and validation.
    Oliveira EF; Valério BCO; Cavalcante V; Urbano JJ; Silva AS; Polaro MN; Nacif SR; Oliveira CS; Resende MBD; Oliveira ASB; Oliveira LVF
    Arq Neuropsiquiatr; 2017 Jul; 75(7):457-463. PubMed ID: 28746433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defining Thresholds for the Patient Acceptable Symptom State for the IKDC Subjective Knee Form and KOOS for Patients Who Underwent ACL Reconstruction.
    Muller B; Yabroudi MA; Lynch A; Lai CL; van Dijk CN; Fu FH; Irrgang JJ
    Am J Sports Med; 2016 Nov; 44(11):2820-2826. PubMed ID: 27474383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.